Abstract:Magnesium ions (Mg2+) are bioactive and proven to promote bone tissue regeneration, in which the enhancement efficiency is closely related to Mg2+ concentrations. Currently, there are no well-established bone tissue engineering scaffolds that can precisely control Mg2+ release, although this capability could have a marked impact in bone regeneration. Leveraging the power of biodegradable microspheres to control the release of bioactive factors, we developed lactone-based biodegradable microspheres that served as both injectable scaffolds and Mg2+ release system for bone regeneration. The biodegradable microsphere (PMg) was prepared from poly(lactide-co-glycolide) (PLGA) micro-spheres co-embedded with MgO and MgCO3 at a fixed total loading amount (20 wt%) with different weight ratios (1:0; 3:1; 1:1; 1:3; 0:1). The PMg microspheres demonstrated controlled release of Mg2+ by tuning the MgO/MgCO3 ratios. Specifically, faster release with higher initial concentrations of Mg2+ were detected at higher MgO fractions, while long-term sustained release with lower concentrations of Mg2+ was obtained at higher MgCO3 fractions. All prepared PMg microspheres were non-cytotoxic. Furthermore, they promoted attachment, proliferation, osteogenic differentiation, especially, cell migration of bone marrow mesenchymal stromal cells (BMSCs). Among these microspheres, PMg-III microspheres (MgO/MgCO3 in 1:1) exhibited the strongest promotion of mineral depositions and osteogenic differentiation of BMSCs. PMg-Ill microspheres were injected into the critical-sized calvarial defect of a rat model, resulting in significant bone regeneration when compared to the control group filled with PLGA microspheres. In the PMg-Ill group, the new bone volume fraction (BV/TV) and bone mineral density (BMD) reached 32.9 +/- 5.6% and 325.7 +/- 20.2 mg/cm(3), respectively, which were much higher than the values 8.1 +/- 2.5% (BV/TV) and 124 +/- 35.8 mg/cm(3) (BMD) in the PLGA group. These findings indicated that bioresorbable microspheres possessing controlled Mg2+ release features were efficient in treating bone defects and promising for future in vivo applications. Statement of Significance Magnesium plays pivotal roles in regulating osteogenesis, which exhibits concentration-dependent behaviors. However, no generally accepted controlled-release system is reported to correlate Mg2+ concentration with efficient bone regeneration. Biodegradable microspheres with injectability are excellent cell carriers for tissue engineering, moreover, good delivery systems for bioactive factors. By co-embedding magnesium compounds (MgO, MgCO3) with different dissolution rates in various ratios, tunable release of Mg2+ from the microspheres was readily achieved. Accordingly, significant promotion in bone defect regeneration is achieved with microspheres displaying proper sustained release of Mg2+. The developed strategy may serve as valuable guidelines for bone tissue engineering scaffold design, which allows precise control on the release of bioactive metal ions like Mg2+ toward potential clinical translation. (C) 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Sustained release of melatonin from poly (lactic-co-glycolic acid) (PLGA) microspheres to induce osteogenesis of human mesenchymal stem cells in vitro.

Microsphere-based drug releasing scaffolds for inducing osteogenesis of human mesenchymal stem cells in vitro.

Sustained Release of Melatonin from GelMA Liposomes Reduced Osteoblast Apoptosis and Improved Implant Osseointegration in Osteoporosis

Melatonin enhances chondrogenic differentiation of human mesenchymal stem cells.

Injectable PLGA Microspheres with Tunable Magnesium Ion Release for Promoting Bone Regeneration.

Melatonin and calcium phosphate crystal-loaded poly(L-lactic acid) porous microspheres reprogram macrophages to improve bone repair

Melatonin rescues the mitochondrial function of bone marrow-derived mesenchymal stem cells and improves the repair of osteoporotic bone defect in ovariectomized rats

Melatonin enhances osteogenic differentiation of dental pulp mesenchymal stem cells by regulating MAPK pathways and promotes the efficiency of bone regeneration in calvarial bone defects

PLGA porous microspheres enhancing the osteogenesis of MC 3 T 3E 1 cells

Enhancement of Bone Formation by Bone Morphogenetic Protein-2 Released from Poly (L-Lactic-co-glycolic Acid) Microsphere

Sustained release poly (lactic-co-glycolic acid) microspheres of bone morphogenetic protein 2 plasmid/calcium phosphate to promote in vitro bone formation and in vivo ectopic osteogenesis.

Precisely controlled delivery of magnesium ions thru sponge-like monodisperse PLGA/nano-MgO-alginate core-shell microsphere device to enable in-situ bone regeneration

Development of poly(lactide-co-glycolide) microparticles for sustained delivery of meloxicam

In Vivo and in Vitro Osteogenesis of Stem Cells Induced by Controlled Release of Drugs from Microspherical Scaffolds

Multilayered pore-closed PLGA microsphere delivering OGP and BMP-2 in sequential release patterns for the facilitation of BMSCs osteogenic differentiation.

Preparation of 25-dihydroxy-vitamin D3-poly lactic acid microspheres and the effect on bone marrow mesenchymal stem cell proliferation

Preparation and characterization of poly (lactic-co-glycolic acid) microspheres for controlled release of osteogenic growth peptide

Melatonin Induces Osteoblastic Differentiation of Mesenchymal Stem Cells and Promotes Fracture Healing in a Rat Model of Femoral Fracture via Neuropeptide Y/Neuropeptide Y Receptor Y1 Signaling

Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPARγ expression and enhancing Runx2 expression.

A novel poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV)-PEG-melatonin composite scaffold enhances for inhibiting bone tumor recurrence and enhancing bone regeneration

Photoluminescent Polyphosphazene Nanoparticles for in Situ Simvastatin Delivery for Improving the Osteocompatibility of BMSCs